senior convertible notes | GenomeWeb

senior convertible notes

The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.

The firm privately negotiated the exchange with current holders of convertible notes due 2017.

Quidel will use the net proceeds from the offering for working capital and other general corporate purposes.

PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Wednesday that it successfully completed the previously announced repurchase of convertible notes due in 2026 and the issuance

NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Monday that it has given notice of its intention to redeem all of its outstanding 3.50 percent senior convertible notes due 2038.

As of May 6, there was $350 million in aggregate principal amount of the notes outstanding.

Net proceeds from the offering will be used to buy back common stock, fund conversion on currently outstanding convertible notes, and general corporate purposes.

The firm intends to redeem all of the outstanding 2 percent convertible senior notes due 2023.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.